Genedata Expressionist

Genedata Expressionist® is an enterprise software platform designed to streamline mass spectrometry (MS) workflows across instruments and teams in biopharma organizations. By automating and harmonizing MS data processes, it delivers high-quality, reproducible results quickly and cost-effectively, enhancing data accuracy, consistency, and regulatory compliance throughout the analytical pipeline. The platform is built for scientific teams involved in biotherapeutic development, from early discovery through manufacturing and quality control.

Genedata Expressionist eliminates the costs and complexity of maintaining multiple software packages by consolidating MS data processing, analysis, and reporting into a single open, scalable enterprise solution. Its flexible workflow-based architecture enables tailored solutions that align with existing processes, meet specific business and technical requirements, and transform raw MS data into actionable insights. Leading biopharma organizations have reported up to 100-fold increases in screening throughput, the ability to process approximately 500 samples in a process characterization study in under one week with a single operator and reviewer, and dramatically improved capacity for handling large, complex data files in high-throughput screening.

Key Application Areas

• Enhanced Biotherapeutic Characterization: Supports best-in-class molecular characterization for MS-based approaches including peptide mapping, released glycans, and intact mass analysis. Enables comprehensive characterization of charge variants, antibody-drug conjugates, and protein glycoforms, as well as rapid, high-confidence identification of released glycans and glycosylated peptides and proteins.
• Optimized Quality Monitoring: Extends quality oversight with automated, process-specific system suitability tests (SSTs) that verify instrument performance before data analysis. Automatically generates and distributes custom-built reports to stakeholders, supporting GxP-compliant implementations in regulated environments.
• Streamlined MAM Implementation: Combines in-depth characterization and automated Critical Quality Attribute (CQA) monitoring in a single platform, supporting end-to-end multi-attribute method (MAM) implementations within a Quality-by-Design framework. A centralized knowledge base captures product information throughout the drug lifecycle.
• High-Sensitivity MS-Based Contaminant Detection: Provides flexible workflows for identifying and quantifying host cell proteins (HCPs) and other product and process-related contaminants. Applies consistency checks to distinguish real signals from noise and builds isotope clusters based on known isotopic patterns to detect HCPs down to low-ppm levels with high confidence.
• Holistic Bioprocess Monitoring: Supports a harmonized, multi-omic approach to monitoring biotherapeutic production across all biopharma MS applications and instruments. Includes integrated statistical analysis tools such as Principal Component Analysis (PCA) and Partial Least Squares (PLS) to uncover relationships across complex multi-omics datasets.
• RNA and Oligonucleotide Development: Provides a flexible platform for MS data processing, analysis, and reporting for RNA-based therapeutics and oligonucleotides, from early discovery through regulated environments, leveraging MS sensitivity for in-depth characterization and quality monitoring.

Core Platform Capabilities

• Fully automated workflows that eliminate repetitive manual tasks, reduce human error, and ensure consistent, reproducible results, allowing scientists to focus on result interpretation.
• High-performance, server-based infrastructure capable of processing datasets of any size or complexity, supporting high-throughput processing of thousands of samples for large-scale studies and QC operations.
• Configurable workflow steps that give users full control over data processing, combined with intuitive visualizations that link raw and processed data for deeper interrogation and faster interpretation.
• Standardized and validated analysis pipelines that enforce consistent processing protocols, minimize variability, and ensure high data integrity and accuracy across studies and batches.
• Advanced data workflow management capabilities that break down data barriers, facilitate global collaboration, and harmonize analytical processes across departments, labs, and sites.
• Machine learning and AI-based capabilities to support drug discovery and biologics development.

Compliance and Enterprise Deployment

• Full support for GxP deployment and 21 CFR Part 11 requirements, ensuring data security, integrity, and traceability in regulated biopharmaceutical environments.
• Built-in compliance features including user role management, time-stamped audit trails, immutable electronic records, and robust version control to streamline regulatory submissions.
• Scalable enterprise architecture designed for global deployment, enabling different groups, labs, and sites to customize workflows while maintaining centralized data access and harmonized MS processes.

Genedata Expressionist is supported by a team of scientific experts who assess customer analytical workflows to design and implement ready-to-use solutions, combining consolidated domain knowledge with out-of-the-box performance to rapidly transform complex MS data into actionable insights across the full biopharma lifecycle.